bpc-157 fda approval status human use NBC News | The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger-looking skin, FDA panel backs compounded BPC-157,

DUAL GLUCAGON/GLUCAGON-LIKE PEPTIDE-1 RECEPTOR CO-AGONISTS As part of the ongoing effort to use synergistic effects of gastrointestinal hormones in the treatment of diabetes and obesity, the first GIP/GLP-1 receptor co-agonist was reported in 2013

Anti-Fibrotic Properties CKD progression is largely driven by fibrosis

We have created export routes to more than 100 countries in Europe, the United States, Japan, and South Korea

If the injection is needed (e.g., to replete B or B in a deficient mother), it can be used, but the infant should be observed for any unusual symptoms (though none would be expected from B vitamins, apart from perhaps looser stools if anything)

Gurram PC, Manandhar S, Satarker S et al (2025) Substance P mitigates lipopolysaccharide induced cognitive impairment in rats in a dose dependent manner